• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Inflammation . Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting M pro and Sepsis in Mice

tetano

Editor, Senior Moderator
Inflammation


. 2021 Nov 25.
doi: 10.1007/s10753-021-01602-z. Online ahead of print.
Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting M [SUP]pro[/SUP] and Sepsis in Mice


Ting Xiao[SUP] #[/SUP][SUP] 1 2 [/SUP], Mengqi Cui[SUP] #[/SUP][SUP] 1 2 [/SUP], Caijuan Zheng[SUP] #[/SUP][SUP] 1 [/SUP], Peipei Zhang[SUP] #[/SUP][SUP] 3 [/SUP], Shanfa Ren[SUP] 1 2 [/SUP], Jiali Bao[SUP] 1 2 [/SUP], Dandi Gao[SUP] 1 2 [/SUP], Ronghao Sun[SUP] 1 2 [/SUP], Ming Wang[SUP] 1 [/SUP], Jianping Lin[SUP] 1 [/SUP], Liang Zhang[SUP] 4 [/SUP], Mingjiang Li[SUP] 4 [/SUP], Dongmei Li[SUP] 5 [/SUP], Honggang Zhou[SUP] 6 7 [/SUP], Cheng Yang[SUP] 8 9 [/SUP]



Affiliations

Abstract

The emergence of severe acute syndrome coronavirus 2 (SARS-CoV-2) in December 2019 has led to the global COVID-19 pandemic. Although the symptoms of most COVID-19 patients are mild or self-curable, most of severe patients have sepsis caused by cytokine storms, which greatly increases the case fatality rate. Moreover, there is no effective drug that can limit the novel coronavirus thus far, so it is more needed to develop antiviral drugs for the SARS-CoV-2. In our research, we employed the techniques of molecular docking to screen 35 flavonoid compounds among which 29 compounds have Z-scores lower than - 6. Then, ( -)-gallocatechin gallate, ( +)-gallocatechin and baicalein were identified to have potent inhibitory activity against SARS-CoV-2 M[SUP]pro[/SUP] with IC[SUB]50[/SUB] values of 5.774 ± 0.805 μM, 13.14 ± 2.081 μM and 5.158 ± 0.928 μM respectively by FRET assay. Molecular docking results also showed that ( -)-gallocatechin gallate, ( +)-gallocatechin and baicalein can non-covalently bind to M[SUP]pro[/SUP] through π-π stacking and hydrogen bonds in the Cys145 catalytic site. We further evaluated the effect of ( -)-gallocatechin gallate and baicalein on cytokine storms using a mouse model of sepsis. ( -)-Gallocatechin gallate and baicalein significantly reduced sepsis of mouse models on weight, murine sepsis score, and survival rate and reduced the inflammatory factor levels, such as TNF-α, IL-1α, IL-4, and IL-10. Overall, ( -)-gallocatechin gallate and baicalein show certain potential of treatment against COVID-19.

Keywords: Mpro protease; SARS-CoV-2; cytokine storm; flavonoids; sepsis.
 
Back
Top Bottom